Shopping Cart
- Remove All
- Your shopping cart is currently empty
Becampanel (AMP397) is the first competitive AMPA antagonist and functions as an antiepileptic agent.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Becampanel (AMP397) is the first competitive AMPA antagonist and functions as an antiepileptic agent. |
In vitro | Becampanel showed no activity in the mouse lymphoma tk assay without metabolic activation (S9) after a 24-hour treatment. However, it weakly induced micronuclei formation at the highest tested concentrations in V79 cells when metabolic activation (S9) was present[1]. |
In vivo | Becampanel demonstrated no genotoxic potential in vivo, evidenced by its negative results in studies including those at maximum tolerated doses of 320 mg/kg in mice and 2000 mg/kg in rats[1]. |
Alias | AMP 397 |
Molecular Weight | 330.19 |
Formula | C10H11N4O7P |
Cas No. | 188696-80-2 |
Relative Density. | 1.702g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.